The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Jul. 13, 2017
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Alexander Sing Cheung, Cambridge, MA (US);

David J. Mooney, Sudbury, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 35/17 (2015.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61L 27/02 (2006.01); A61L 27/28 (2006.01); A61L 27/38 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0075 (2013.01); A61K 9/0019 (2013.01); A61K 35/17 (2013.01); A61K 38/1841 (2013.01); A61K 38/193 (2013.01); A61K 38/2013 (2013.01); A61K 39/0011 (2013.01); A61K 39/395 (2013.01); A61L 27/025 (2013.01); A61L 27/28 (2013.01); A61L 27/3804 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61P 35/00 (2018.01); C12N 5/0638 (2013.01); A61L 2300/426 (2013.01); A61L 2300/45 (2013.01); C12N 2501/15 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/998 (2013.01); C12N 2533/00 (2013.01); C12N 2533/20 (2013.01);
Abstract

Embodiments herein described provide antigen-presenting cell-mimetic scaffolds (APC-MS) and use of such scaffolds to manipulating T-cells. More specifically, the scaffolds are useful for promoting growth, division, differentiation, expansion, proliferation, activity, viability, exhaustion, anergy, quiescence, apoptosis, or death of T-cells in various settings, e.g., in vitro, ex vivo, or in vivo. Embodiments described herein further relate to pharmaceutical compositions, kits, and packages containing such scaffolds. Additional embodiments relate to methods for making the scaffolds, compositions, and kits/packages. Also described herein are methods for using the scaffolds, compositions, and/or kits in the diagnosis or therapy of diseases such as cancers, immunodeficiency disorders, and/or autoimmune disorders.


Find Patent Forward Citations

Loading…